SUCCESSFUL CLINICAL OUTCOMES AND COST SAVINGS ASSOCIATED WITH A 12-HOUR IV CEFTIZOXIME REGIMEN

Authors
MUCCIARDI N SESIN GP GANNON P
Citation
N. Mucciardi et al., SUCCESSFUL CLINICAL OUTCOMES AND COST SAVINGS ASSOCIATED WITH A 12-HOUR IV CEFTIZOXIME REGIMEN, Formulary, 31(4), 1996, pp. 304-306
Citations number
5
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Formulary → ACNP
ISSN journal
1082801X
Volume
31
Issue
4
Year of publication
1996
Pages
304 - 306
Database
ISI
SICI code
1082-801X(1996)31:4<304:SCOACS>2.0.ZU;2-X
Abstract
A medication use monitor (MUM) was conducted at our institution to doc ument utilization and outcome data for IV ceftizoxime (Cefizox) dosed at 12-hour intervals. This evaluation followed the implemenentation of a therapeutic interchange policy of IV ceftizoxime for-IV ceftriaxone (Rocephin). A satisfactory clinical outcome was achieved in 99% (457 of 460) of the cases. Estimated cost-avoidance exceeded $80,000 for 1 year.